Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 3, 2012
Paris, France and Miami Beach, FL (February 3, 2012) – Boston Scientific Corporation (NYSE: BSX) announces CE Mark approval of the Infinion™ 16 Percutaneous Lead for its Precision Plus™...
-
Feb 2, 2012
Boston Scientific Corporation (NYSE: BSX) announces financial results for the fourth quarter and full year ended December 31, 2011, as well as sales and...
-
Feb 1, 2012Platinum chromium coronary stent with enhanced delivery system now available in Europe and other international countries
Boston Scientific Corporation (NYSE: BSX) announces first patient use and European market launch of the PROMUS Element™ Plus Everolimus-Eluting...
-
Jan 31, 2012
Singapore (January 31, 2012) – Boston Scientific Corporation (NYSE: BSX) announces the creation of its Asia-Pacific regional organization that includes Australia, New Zealand, China, Hong Kong,...
-
Jan 26, 2012NICE Report Supports Safety and Effectiveness of Alair® System
London (January 26, 2012) -- Boston Scientific (UK) welcomes new guidance from the National Institute for Health and Clinical Excellence (NICE) on the use of Bronchial Thermoplasty (BT) to treat...